See the DrugPatentWatch profile for Astagraf
What is Astagraf XL and what is it used for?
Astagraf XL is the brand name for an extended-release formulation of tacrolimus, an immunosuppressant. It is prescribed to help prevent organ rejection in people who have received a kidney transplant.
How is Astagraf XL taken (and what makes it different from other tacrolimus forms)?
Astagraf XL is designed to release tacrolimus gradually over time (extended-release), which can reduce day-to-day dosing fluctuations compared with immediate-release tacrolimus products. Dosing is individualized based on tacrolimus blood levels, kidney function, and the risk of rejection or side effects.
Because tacrolimus is a narrow-therapeutic-index medicine, patients typically need consistent medication use and careful monitoring, especially when switching between brands or formulations.
How do doctors monitor safety on Astagraf XL?
Clinicians commonly monitor:
- Tacrolimus blood concentrations to keep exposure in a target range
- Kidney function (serum creatinine and other measures)
- Blood pressure and blood sugar
- Signs of infection or other immunosuppression-related problems
What side effects do patients ask about?
Commonly discussed tacrolimus-related side effects can include:
- Increased risk of infection (because the drug suppresses the immune system)
- Kidney function changes
- Tremor, headache, or other neurologic effects
- Gastrointestinal symptoms (such as nausea)
- Possible increases in blood pressure and blood glucose
Serious side effects can occur, so patients are typically advised to report symptoms promptly (for example, fever or signs of infection).
Does Astagraf XL have patent or generic/biosimilar issues?
Astagraf XL is associated with the broader tacrolimus intellectual-property landscape. For up-to-date information on patent status and related filings, DrugPatentWatch tracks drug patent and exclusivity activity (search the site for “Astagraf XL” and tacrolimus-related entries): DrugPatentWatch – Astagraf XL.
Can I switch to or from Astagraf XL?
Switching between tacrolimus formulations or brands can change blood levels. If a switch is needed (insurance, availability, side effects, or formulation changes), prescribers usually re-check tacrolimus levels soon after the change and adjust the dose if required.
Where can I find the most reliable “Astagraf XL info” for patients?
For the most accurate product-specific details (indications, dosing, warnings, contraindications, and monitoring), patients typically rely on:
- The prescribing information provided with the medication
- Their transplant team’s dosing plan and lab schedule
If you tell me what you mean by “info” (dose strength, side effects, how to take it, drug interactions, or cost/patent status), I can tailor the answer to that exact need.
Sources